High Denial Rates for Rehabilitation Services in Medicare Advantage Plans
Patients enrolled in major Medicare Advantage plans across the United States are experiencing excessive denial rates for rehabilitation and other crucial services, as revealed in a recent report from the Department of Health and Human Services’ inspector general.
Growing Concerns Over Pre-Authorization Practices
This alarming trend has prompted heightened scrutiny of insurers’ use of pre-authorization—a cost-control mechanism that experts argue often results in unnecessary delays or outright denials of essential treatments. The report indicates that denial rates for long-term care services can fluctuate dramatically, with some companies reporting rates as high as 80%.
Insight from Health Policy Experts
Miranda Yarber, an assistant professor of health policy and management at the University of Pittsburgh, expressed dismay over these findings, noting, “These denial rates are quite staggering.” She emphasized that this pattern reinforces long-held frustrations among Americans, suggesting that profit motives are prevailing over actual medical necessity.
Shocking Variability Among Insurers
HHS Deputy Inspector General Erin Bliss expressed her surprise at the significant variance in denial rates, which range from 8% to 80% across different companies. This inconsistency raises critical questions about the fairness and efficacy of the prior authorization process.
Appeals and Audit Findings
In a second report released simultaneously, an analysis of prior authorization applications for skilled nursing facility care found that insurers overturned 95% of denials when patients filed appeals. Lead author Rosemary Bartholomew raised alarms about high turnover rates, suggesting potential flaws in the initial request assessment.
Reform Initiatives in Motion
Secretary of Health Robert F. Kennedy Jr. has pledged to reform the prior authorization process. Initiatives announced last year aimed to streamline the procedures employed by major health insurance companies. In a positive development, the industry group AHIP reported that major health plans had reduced prior authorization requirements by 11% for various medical services. Notably, UnitedHealthcare revealed that it had removed two-thirds of its licensing requisites for children.
Impact of Denials on Patients
Challenges remain in realizing the efficacy of these reforms, as experts caution that the real impact on patient care delays will take time to assess. The inspector general’s report focused on requests made in June 2024 among 19 Medicare Advantage groups, revealing troubling denial rates across these plans. Services like long-term acute care and inpatient rehabilitation—vital for patients recovering from severe health issues—carry substantial costs, averaging $49,000 for long-term acute care and $24,000 for inpatient rehabilitation in 2023.
Major Players in the Medicare Advantage Space
Notably, UnitedHealthcare, CVS Health, and Humana topped the list for the highest denial rates in these services, rejecting over 70% of prior authorization requests in some instances. With nearly 20 million Americans enrolled in Medicare Advantage plans managed by these three companies, the implications are profound. When treatment requests are denied, patients frequently find themselves forced to shoulder costs out of pocket or receive inferior care.
Recommendations for Regulatory Oversight
In light of these findings, the Office of Inspector General recommends that the Centers for Medicare and Medicaid Services (CMS) enhance its data collection on prior authorization to comprehensively investigate the issue. Additionally, the report calls for scrutiny into the wide discrepancies in denial rates among insurers, suggesting a need for greater regulatory oversight.
Understanding Denial Causes
Insurers often defend prior authorization as a means of controlling healthcare expenses by curtailing unnecessary tests and treatments. In a statement, Aetna—a part of CVS Health—asserted its commitment to prompt reviews and patient-centered improvements. However, representatives from UnitedHealthcare and Humana did not respond to inquiries for comment.
The Role of Providers in Denial Rates
Meredith Fried, a senior policy manager at KFF, noted that some denials can stem from provider errors, such as incomplete documentation or incorrect billing codes. Nonetheless, she cautioned that the unusually high denial rates highlighted in the HHS report raise significant concerns about inappropriate care denials.
Discrepancies in Denial Rates
The findings also revealed that commercial insurers tended to deny prior authorizations more frequently than their nonprofit counterparts. This raises questions about potential profit motivations among private insurers. Yarber further emphasized the troubling nature of these variations in refusal rates, suggesting that cost considerations are inseparable from the calculations guiding coverage decisions.
